Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro

Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a promising approach to treat TNBC. However, oncolytic adenovirus (OAd)-based mono-therapeutic clinical trials have resulted in mod...

Full description

Bibliographic Details
Main Authors: Rodolfo Garza-Morales, Roxana Gonzalez-Ramos, Akiko Chiba, Roberto Montes de Oca-Luna, Lacey R. McNally, Kelly M. McMasters, Jorge G. Gomez-Gutierrez
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Cancers
Subjects:
oncolytic
adenovirus
triple-negative
breast cancer
temozolomide
autophagy
virotherapy
Online Access:http://www.mdpi.com/2072-6694/10/5/144

Internet

http://www.mdpi.com/2072-6694/10/5/144

Similar Items